{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:15:04Z","timestamp":1781954104149,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":704,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1111\/jth.15116","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T18:07:41Z","timestamp":1601489261000},"page":"96-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1818-3872","authenticated-orcid":false,"given":"Eugenia","family":"Biguzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Maria","family":"Siboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"le Cessie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Baronciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"van Hylckama Vlieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-9864","authenticated-orcid":false,"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1111\/jth.15116_bb0010","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1111\/jth.15116_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15565","article-title":"von Willebrand factor clearance \u2010 biological mechanisms and clinical significance","volume":"183","author":"O'Sullivan","year":"2018","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1111\/jth.15116_bb0020","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"issue":"20","key":"10.1111\/jth.15116_bb0025","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1111\/jth.15116_bb0030","first-page":"89","article-title":"Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level","volume":"37","author":"Orstavik","year":"1985","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1111\/jth.15116_bb0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1649589","article-title":"Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"70","author":"Conlan","year":"1993","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1111\/jth.15116_bb0040","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.1997.1222936.x","article-title":"Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use","volume":"97","author":"Lowe","year":"1997","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1111\/jth.15116_bb0045","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1309\/W76QF806CE80CL2T","article-title":"Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis","volume":"124","author":"Favaloro","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1111\/jth.15116_bb0050","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1111\/jth.15116_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"8","key":"10.1111\/jth.15116_bb0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2018-10-844936","article-title":"How I treat low von Willebrand factor levels","volume":"133","author":"Lavin","year":"2019","journal-title":"Blood"},{"key":"10.1111\/jth.15116_bb0065","article-title":"How we make an accurate diagnosis of von Willebrand disease","author":"Baronciani","year":"2019","journal-title":"Thromb Res"},{"issue":"3","key":"10.1111\/jth.15116_bb0070","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1055\/s-0038-1657699","article-title":"A type 2b von Willebrand disease mutation (Ile546\u2013>Val) associated with an unusual phenotype","volume":"78","author":"Federici","year":"1997","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1111\/jth.15116_bb0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2141.1976.tb03533.x","article-title":"Immunoradiometric assay of factor VIII related antigen, with observations in 32 patients with von Willebrand's disease","volume":"33","author":"Ruggeri","year":"1976","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1111\/jth.15116_bb0080","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1055\/s-0038-1665330","article-title":"Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables","volume":"50","author":"Wahlberg","year":"1983","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1111\/jth.15116_bb0085","first-page":"77","article-title":"A sensitive ristocetin co\u2010factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici","year":"2004","journal-title":"Haematologica"},{"issue":"3","key":"10.1111\/jth.15116_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.thromres.2010.06.013","article-title":"Validation of a rapid test (VWF\u2010LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM\u20101VWD","volume":"126","author":"Castaman","year":"2010","journal-title":"Thromb Res"},{"issue":"7","key":"10.1111\/jth.15116_bb0095","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet\u2010dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bodo","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1111\/jth.15116_bb0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00001721-200408000-00011","article-title":"A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000)","volume":"15","author":"Lattuada","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1111\/jth.15116_bb0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3324\/haematol.10766","article-title":"Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease","volume":"92","author":"Pinol","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1111\/jth.15116_bb0110","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/hae.12203","article-title":"Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor\u2010induced platelet agglutination method","volume":"19","author":"Cabrera","year":"2013","journal-title":"Haemophilia"},{"issue":"7","key":"10.1111\/jth.15116_bb0115","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/jth.12586","article-title":"von Willebrand disease and aging: an evolving phenotype","volume":"12","author":"Sanders","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1111\/jth.15116_bb0120","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/hae.12664","article-title":"Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease","volume":"21","author":"Rydz","year":"2015","journal-title":"Haemophilia"},{"issue":"2","key":"10.1111\/jth.15116_bb0125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajh.24962","article-title":"Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: a two decade study","volume":"93","author":"Abou\u2010Ismail","year":"2018","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1111\/jth.15116_bb0130","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.3324\/haematol.2017.168013","article-title":"Increase of von Willebrand factor with aging in type 1 von Willebrand disease: fact or fiction?","volume":"102","author":"Borghi","year":"2017","journal-title":"Haematologica"},{"key":"10.1111\/jth.15116_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.04.001","article-title":"Evolution of replacement therapy for von Willebrand disease: from plasma fraction to recombinant von Willebrand factor","volume":"38","author":"Peyvandi","year":"2019","journal-title":"Blood Rev"},{"issue":"1","key":"10.1111\/jth.15116_bb0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bjh.15277","article-title":"Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age\u2010related increase of VWF in von Willebrand disease","volume":"182","author":"Atiq","year":"2018","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15116","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622004299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622004299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:30:49Z","timestamp":1761535849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622004299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1538783622004299"],"URL":"https:\/\/doi.org\/10.1111\/jth.15116","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}